Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride to Reduce Acute Urinary Retention Relapse After Trial Without Catheter
2006-003023-37Phase 4Terminated
- Sponsor
- GSK
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in benign prostatic hyperplasia (BPH) and urinary retention comparing Dutasteride arm with Placebo arm (2 arms). Primary endpoint: Acute urinary retention relapse rate over 24 weeks. Started Aug 2006; status: terminated.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)urinary retention
Beyond the preview
Go deeper on 2006-003023-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003023-37.